Taxus Cardium Pharmaceuticals Price Prediction

CRXMDelisted Stock  USD 0.0001  0.00  0.00%   
As of now the relative strength index (rsi) of Taxus Cardium's share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

0

 
Oversold
 
Overbought
The successful prediction of Taxus Cardium's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Taxus Cardium and does not consider all of the tangible or intangible factors available from Taxus Cardium's fundamental data. We analyze noise-free headlines and recent hype associated with Taxus Cardium Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using Taxus Cardium hype-based prediction, you can estimate the value of Taxus Cardium Pharmaceuticals from the perspective of Taxus Cardium response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Taxus Cardium to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Taxus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Taxus Cardium after-hype prediction price

    
  USD 1.0E-4  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Taxus Cardium's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.000.0000850.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

Taxus Cardium After-Hype Price Prediction Density Analysis

As far as predicting the price of Taxus Cardium at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Taxus Cardium or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Taxus Cardium, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Taxus Cardium Estimiated After-Hype Price Volatility

In the context of predicting Taxus Cardium's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Taxus Cardium's historical news coverage. Taxus Cardium's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Taxus Cardium's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.0001
0.0001
After-hype Price
0.00
Upside
Taxus Cardium is very steady at this time. Analysis and calculation of next after-hype price of Taxus Cardium Pharma is based on 3 months time horizon.

Taxus Cardium Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Taxus Cardium is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Taxus Cardium backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Taxus Cardium, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
10 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.0001
0.0001
0.00 
0.00  
Notes

Taxus Cardium Hype Timeline

Taxus Cardium Pharma is currently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Taxus is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Taxus Cardium is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company recorded a loss per share of 0.02. Taxus Cardium Pharma had not issued any dividends in recent years. The entity had 1:20 split on the 18th of July 2013. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Taxus Cardium Related Hype Analysis

Having access to credible news sources related to Taxus Cardium's direct competition is more important than ever and may enhance your ability to predict Taxus Cardium's future price movements. Getting to know how Taxus Cardium's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Taxus Cardium may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
DFFNDiffusion Pharmaceuticals 0.1 5 per month 0.00 (0.19) 4.09 (5.32) 12.34 
ACSTAcasti Pharma(0.19)4 per month 2.83  0.07  9.42 (3.85) 25.09 
ADXSAyala Pharmaceuticals 0.00 0 per month 12.67  0.09  30.59 (15.09) 115.09 
ONTXOnconova Therapeutics 0.00 0 per month 4.35  0.09  7.69 (8.33) 66.73 
ARDSAridis Pharmaceuticals 0.01 58 per month 7.66  0.07  12.50 (12.50) 140.53 
RVMDRevolution Medicines(2.38)8 per month 3.03 (0) 4.81 (5.31) 16.40 
BPMCBlueprint Medicines Corp(2.63)12 per month 2.17  0.06  3.92 (3.25) 14.28 
SANASana Biotechnology(0.22)11 per month 0.00 (0.21) 9.02 (9.82) 28.04 
KYMRKymera Therapeutics 0.38 9 per month 0.00 (0.07) 4.84 (5.65) 18.10 
GLUEMonte Rosa Therapeutics 0.84 9 per month 4.13  0.07  8.40 (8.46) 103.72 
AKBAAkebia Ther 0.1 7 per month 2.29  0.12  6.22 (4.23) 26.21 
RAREUltragenyx 0.18 13 per month 0.00 (0.24) 2.65 (3.40) 8.35 
ERASErasca Inc(0.21)7 per month 0.00 (0.02) 7.42 (6.08) 20.29 
CABACabaletta Bio(0.30)7 per month 0.00 (0.03) 10.80 (11.02) 40.71 
REPLReplimune Group(0.70)8 per month 3.36  0.04  8.25 (5.60) 46.30 

Taxus Cardium Additional Predictive Modules

Most predictive techniques to examine Taxus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Taxus using various technical indicators. When you analyze Taxus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Taxus Cardium Predictive Indicators

The successful prediction of Taxus Cardium stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Taxus Cardium Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Taxus Cardium based on analysis of Taxus Cardium hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Taxus Cardium's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Taxus Cardium's related companies.

Story Coverage note for Taxus Cardium

The number of cover stories for Taxus Cardium depends on current market conditions and Taxus Cardium's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Taxus Cardium is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Taxus Cardium's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Taxus Cardium Short Properties

Taxus Cardium's future price predictability will typically decrease when Taxus Cardium's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Taxus Cardium Pharmaceuticals often depends not only on the future outlook of the potential Taxus Cardium's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Taxus Cardium's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding14.5 M
Cash And Short Term Investments386 K
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in Taxus Pink Sheet

If you are still planning to invest in Taxus Cardium Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taxus Cardium's history and understand the potential risks before investing.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Correlations
Find global opportunities by holding instruments from different markets
Stocks Directory
Find actively traded stocks across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.